This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

The Deal: European Stocks Rally as Fed Trims Stimulus

LONDON (The Deal) -- European stock indices rallied and Asian markets were mixed  Thursday after the Federal Reserve said it would pare back its $85 billion monthly bond buying program by $10 billion starting in January and made reassuring comments about the outlook for interest rates.

The central bank said it doesn't foresee rates moving much beyond zero until well past the time  unemployment in the U.S. falls  below 6.5%.

In London, the FTSE was up 0.92% at 6,551.93.  U.K. retail sales data for November confirmed a picture of increasing consumer confidence after an October blip. Sales expanded 2% year-on-year, and were up 0.3% in the month, in line with forecasts.  In Frankfurt, the DAX jumped 1.37% to 9,307.91, and in Paris the CAC was up 1.49% at 4,170.83.

In London, AstraZeneca (AZN) rose after it announced plans to spend up to $4.3 billion buying out partner Bristol-Myers Squibb (BMY) from a diabetes joint venture.  Diabetes is becoming a major problem in many fast-growing emerging-markets where AstraZeneca is already present and the London company wants to tap into that demand.

In Germany, drugmaker Bayer also announced a deal with a partner, Algeta of Norway. It agreed to pay 17.6 billion Norwegian kroner ($2.9 billion) to take over the company, with whom it collaborates on the Xofigo prostrate cancer drug. The offer represents an improvement from an early November proposal from Bayer, which some analysts said at the time already looked pricey.  But shares in both companies rose, with Algeta trading just below the Nkr362 per share offer price.

In Tokyo, the Nikkei rose 1.74% to 15,859.22 as the falling yen, which touched a five-year low against the dollar, aided exporters. The Nikkei is at a six-year high. In Hong Kong, the Hang Seng  fell 1.1% to 22,888.75. Mainland Chinese indices also fell on concerns that a change of government policy will push up financing costs.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $117.82 -0.18%
FB $105.47 0.06%
GOOG $750.27 0.28%
TSLA $231.11 0.64%
YHOO $32.95 -0.63%


Chart of I:DJI
DOW 17,798.49 -14.90 -0.08%
S&P 500 2,090.11 +1.24 0.06%
NASDAQ 5,127.5250 +11.3820 0.22%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs